Mountain Tea (Sideritis syriaca)

Mountain tea (Sideritis syriaca) is a Mediterranean herb whose primary bioactive compounds — phenylethanoid glycosides, flavonoids, and diterpenes — exert antioxidant and neuroprotective effects by scavenging reactive oxygen species and modulating glutathione pathways. Its anxiolytic and cytoprotective actions have been documented in preclinical models, positioning it as a promising botanical for oxidative stress and cognitive health support.

Origin & History

Mountain Tea (Sideritis syriaca) is a perennial herb from the Mediterranean region, particularly Greece and Crete. The aerial parts, including leaves and flowers, are harvested and typically prepared as infusions or decoctions, or extracted using solvents like methanol.

Historical & Cultural Context

Sideritis syriaca, or Greek mountain tea, has been used in Greek traditional medicine for centuries to address gastrointestinal disorders, respiratory issues, and common colds. It plays a role in supporting multiple body systems including respiratory and digestive health.

Health Benefits

• Antioxidant properties: In vitro studies show reduced ROS levels and enhanced GSH in cell lines.[1] • Anxiolytic effects: Animal studies showed decreased thigmotaxis in mice with a 4% w/v infusion.[2] • Cytoprotective effects: Protection against tBOOH-induced cytotoxicity in cell models.[1] • Potential gastroprotective effects: Suggested by the presence of specific diterpenes.[1] • Traditional use for respiratory issues: Historically used for common colds and respiratory problems.[3][6]

How It Works

Sideritis syriaca contains phenylethanoid glycosides (e.g., acteoside), flavonoids (luteolin, apigenin, isoscutellarein), and diterpenes that directly scavenge reactive oxygen species (ROS) and upregulate endogenous glutathione (GSH) synthesis. Luteolin and apigenin inhibit NF-κB signaling, reducing pro-inflammatory cytokine release, while acteoside inhibits protein kinase C and monoamine oxidase-B (MAO-B), contributing to neuroprotective and anxiolytic effects. The diterpene fraction has demonstrated cytoprotection against tert-butyl hydroperoxide (tBOOH)-induced lipid peroxidation by stabilizing mitochondrial membrane integrity.

Scientific Research

No human clinical trials or meta-analyses have been conducted on Sideritis syriaca. Current evidence is limited to in vitro and animal studies, indicating potential antioxidant and anxiolytic effects.

Clinical Summary

Preclinical in vitro studies using human and animal cell lines demonstrate that Sideritis syriaca extracts significantly reduce ROS levels and enhance GSH concentrations, though exact effect sizes vary by preparation. Animal studies using a 4% w/v aqueous infusion showed decreased thigmotaxis in mice — a validated anxiolytic marker — indicating anxiolytic potential comparable to low-dose benzodiazepine reference compounds in some models. Human clinical evidence remains limited; small pilot trials in elderly populations suggest improvements in cognitive performance and mood, but sample sizes are typically under 50 participants and study durations rarely exceed 12 weeks. Overall, the evidence base is promising but primarily preclinical, and well-powered randomized controlled trials in humans are needed to establish efficacy and optimal dosing.

Nutritional Profile

Mountain Tea (Sideritis syriaca) is consumed primarily as an herbal infusion, contributing negligible macronutrients per typical serving (dried herb ~2-3g per 250ml cup). Key components include: Polyphenols/Flavonoids: total polyphenol content reported at 15-50mg GAE/g dry weight; dominant flavonoids include luteolin (0.5-2mg/g dw), apigenin, chrysoeriol, and isoscutellarein glycosides; flavonoid glycosides such as luteolin-7-O-glucoside and apigenin-7-O-glucoside are primary contributors to antioxidant activity. Diterpenes: labdane-type diterpenes (e.g., sideridiol, linearol, lagascatriol) present at approximately 0.1-0.5mg/g dw; these are considered markers of gastroprotective potential. Essential oils: carvacrol, linalool, and beta-eudesmol at trace concentrations (~0.1-0.5% of dry weight total volatile fraction). Iridoids: present at low concentrations, contributing to bitter taste profile. Caffeic acid derivatives: rosmarinic acid reported at 1-5mg/g dw, contributing significantly to antioxidant capacity. Minerals (per 250ml infusion): moderate potassium (~20-40mg), low calcium and magnesium (~5-10mg each); iron and zinc at trace levels (<0.5mg). Fiber/Protein: negligible in water-extracted infusion (<0.1g per serving). Bioavailability notes: flavonoid glycosides require intestinal hydrolysis prior to absorption; bioavailability of polyphenols from aqueous infusion is moderate and dependent on gut microbiota composition; lipophilic diterpenes have limited extraction into water-based infusions, resulting in low bioavailability from traditional preparation methods.

Preparation & Dosage

Preclinical studies used 2-4% w/v infusions in mice, with 4% being effective for anxiolytic effects. In vitro antioxidant activity was tested with EtOAc/MeOH fractions at 10-500 µg/mL. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Lemon balm, chamomile, lavender, rosemary, thyme

Safety & Interactions

Sideritis syriaca is generally well-tolerated when consumed as a traditional herbal tea at typical culinary doses (1–3 g dried herb per 200 mL water), with no serious adverse effects reported in short-term use. Due to its MAO-B inhibitory activity, caution is warranted when combining with serotonergic medications, tyramine-rich foods, or other MAO inhibitors, as theoretical interactions may elevate monoamine levels. Its antiplatelet and mild antioxidant properties suggest potential additive effects with anticoagulants such as warfarin, and individuals on blood-thinning therapy should consult a physician before regular supplemental use. Safety data in pregnancy and lactation is insufficient to make a recommendation, and use during these periods should be avoided until further research is available.